InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
75%
T+90 mean return
+7.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by BIZZARI JEAN-PIERRE, Director. Officer active across 3 companies, notably Halozyme Therapeutics, INC.. In total, 12 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €2.5m. Activity tracked since 5 May 2021. The latest transaction was filed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations12 total
3,135 sharesCommon StockSEC:0001104659-26-075281:0
45,000 shares0Common SharesSEC:0001628280-26-040488:0
12,600 shares@ US$3.0836.7% of flowCommon SharesSEC:0001628280-26-040488:1
12,600 shares@ US$3.5842.7% of flowCommon SharesSEC:0001628280-25-031891:0
6,995 shares@ US$2.8920.7% of flowCommon SharesSEC:0001628280-24-028992:0
40,000 shares0Common SharesSEC:0001628280-24-028355:0
8,065 shares0Common StockSEC:0001415889-23-007687:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002906:0
35,000 shares@ US$41.0130.015% mcap50.0% of flowCommon StockSEC:0001179110-21-008418:0
35,000 shares@ US$41.01350.0% of flowCommon StockSEC:0001179110-21-008418
5,230 sharesRestricted Stock UnitsSEC:0001179110-21-004969
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004969:0
12 of 12 declarations
About BIZZARI JEAN-PIERRE
Jean-Pierre Bizzari is a Director at Halozyme Therapeutics, Inc. He brings valuable expertise in corporate governance and business strategy. His role involves overseeing the company's operations and contributing to strategic decision-making. With a strong background in the biopharmaceutical sector, he is involved in developing innovative solutions to improve patient health.
